Combined treatment group (n=17): |
At study entry | 12.6 (9.3) | 15.2 (11.5) | 28.3 (21.1) |
At 3 years | 14.3 (11.7) | 15.6 (12.4) | 33.3 (19.7) |
p Value | 0.37 | 0.84 | 0.15 |
Combined control group (n=19): |
At study entry | 11.4 (6.4) | 13.0 (7.1) | 19.5 (11.2) |
At 3 years | 13.8 (8.2) | 14.4 (10.0) | 28.7 (16.7) |
p Value | 0.28 | 0.49 | 0.02 |
Fellow eye group (n=7): |
At study entry | 11.1 (4.6) | 13.4 (5.2) | 19.4 (8.5) |
At 3 years | 11.1 (6.2) | 12.5 (8.2) | 20.8 (8.3) |
p Value | 0.55 | 0.96 | 0.37 |
Bilateral drusen group (n=12): |
At study entry | 11.6 (7.4) | 12.7 (8.2) | 19.5 (12.8) |
At 3 years | 15.1 (8.9) | 15.3 (11.0) | 32.7 (18.6) |
p Value | 0.13 | 0.21 | 0.01 |